Kento Manage is a comprehensive, long-term virtual disease management program designed for patients with chronic heart conditions such as ASCVD, heart failure, and AFib. By combining 24/7 remote monitoring, AI-driven insights, and 1:1 clinical coaching, the program ensures patients stay on track with their medications, lifestyle modifications, and overall cardiac care. Through real-time physiologic monitoring, tailored exercise and nutrition plans, and proactive intervention strategies, Kento Manage helps reduce hospital readmissions, prevent disease progression, and improve patient engagement. This program seamlessly integrates with healthcare providers, maximizing value-based care outcomes while keeping patients healthier and more independent.

Kento Health, co-developed with Mayo Clinic, is a digital cardiac care platform providing accessible, adaptable programs to patients across the care continuum of cardiovascular disease, spanning exercise, nutrition, behavioral health, smoking cessation and medication management. Our AI-driven platform leverages the latest clinical literature, and patient-level clinical and biometric monitoring data to deliver personalized care plans to users and real time insights to Kento clinical coaches and external care teams. 

Kento is deployed in several U.S. health systems and we have demonstrated > 90% engagement rate to our programs, providing a proven model for delivering effective, scalable care. 

Kahun's clinically validated AI engine generates dynamic clinical assessments that optimize physician time.

100% referenced to medical sources.

Kahun's clinical reasoning AI engine navigates within 30 Million mapped evidence-based medical insights to perform gold-standard clinical assessments.

Using its evidence based clinical reasoning engine, Kahun helps healthcare organizations maintain a scalable, high value clinical intake process that is transparent and explainable, optimizing physicians overall mind share and documentation time as well as leading to better clinical outcomes.